| Literature DB >> 31118089 |
Michael Yong1, Emily Young1, Jane Lea1, Hannah Foggin1, Erica Zaia1, Frederick K Kozak1, Brian D Westerberg2.
Abstract
OBJECTIVE: Cochlear implantation can result in post-operative vestibular dysfunction of unknown clinical significance. The objective of this study was to characterize the presence, magnitude, and clinical significance of vestibular dysfunction that occurs after pediatric cochlear implantation. DATA SOURCES: The databases Embase, Medline (OvidSP), and PubMed were used. Only articles published in English were included. Grey literature and unpublished sources were also reviewed. STUDY SELECTION: Articles published from 1980 until the present which documented pre-operative and post-operative vestibular testing on children under the age of 18 were used. DATA EXTRACTION: Parameters that were assessed included number of patients, pre- and post-operative vestibular-evoked myogenic potentials (VEMPs), head impulse testing (HIT), calorics, and posturography, timing of pre- and post-operative testing, symptomatology, and other demographic data such as etiology of the hearing loss. DATA SYNTHESIS: Ten articles were included. Relative risk values evaluating the effect of cochlear implantation on vestibular function were calculated for VEMPs and caloric testing due to the availability of published data. I2 values were calculated and 95% confidence intervals were reported. Separate analyses were conducted for each individual study and a pooled analysis was conducted to yield an overall relative risk. Assessment on risk of bias in individual studies and overall was performed.Entities:
Mesh:
Year: 2019 PMID: 31118089 PMCID: PMC6530180 DOI: 10.1186/s40463-019-0341-z
Source DB: PubMed Journal: J Otolaryngol Head Neck Surg ISSN: 1916-0208
Fig. 1Study article inclusion/exclusion algorithm
Study demographics
| Study | Design | Sample size | Mean age | Follow up | Side | Order | Etiology | Imaging malformation | Surgical site | Brand |
|---|---|---|---|---|---|---|---|---|---|---|
| Ajalloueyan | Prospective | 27 | 2 | 6–8 weeks | Unilateral | N/A | Not specified | Not specified | Round Window | “Advanced Bionics Cochlear” and “Cochlear Nucleus” |
| Jin | Not specified | 12 | 3.8 | Not specified | Not specified | N/A | Not specified | Mondini (2), one branch of vestibulocochlear nerve (1), EVA (1) | Not specified | Not specified |
| De Kegel | Prospective | 23 | 7mo | 2 years | Both | Both | Genetic no Syndrome (4), Genetic syndrome (6), Acquired CMV/Meningitis/premature (8), ANSD (3), Unknown (2) | Not specified | Not specified | Not specified |
| Licameli | Prospective | 19 | 8 | 4–6 weeks | Unilateral | N/A | Not specified | Not specified | Not specified | Not specified |
| Devroede | Retrospective | 24 | 6.75 | 90 days post-second implant | Bilateral | Sequential | Syndrome (7), Genetic mutation (7), Meningitis (1), CMV (1), ANSD (2), Unknown (8) | Vestibular (3), cochlear (1), cochleo-vestibular (3) | Antero-inferior | “Cochlear” |
| Psillas | Prospective | 10 | 2.85 | 6 months | Unilateral | N/A | Not specified | Not specified | Antero-inferior | “Freedom” (6) and “Medel Sonata” (4) |
| Xu | Prospective | 31 | 5.5 | 4 weeks | Unilateral | N/A | Not specified | Not specified | Not specified | Not specified |
| Thierry | Retrospective | 12 | 1.9 | 1.4 years | Unilateral | N/A | Genetic (8), Syndrome (7), CMV/meningitis (5), Inner ear / PDS mutation (7), Kallman (1), Unknown (15) | Bilateral malformation (7) | Antero-inferior | “Cochlear” and “Advanced Bionics” |
| Bogle | Retrospective | 5 | 7.73 | Not specified | Unilateral | N/A | Congenital (4), Acquired (1) | No abnormalities | Not specified | Not specified |
| Gupta | Prospective | 23 | 5.48 | 6 weeks | Unilateral | N/A | Not specified | No abnormalities | Anterior-inferior | “Med-El Pulsar” |
| Hazzaa | Prospective | 40 | 5.7 | 1 month and 6 months | Unilateral | N/A | Genetic (21), Syndrome (2), Ototoxicity (2), Perinatal (1), Unkown (13) | Not specified | Not specified | Not specified |
Study vestibular findings
| Study | VEMP | Calorics | vHIT | Non-video HIT | Symptoms |
|---|---|---|---|---|---|
| Ajalloueyan | Pre: 7% (2) no cVEMP bilaterally. 19% (5) no cVEMP unilaterally. | Pre: 8% (1) dysfunction. | Not performed | Pre: 0% had dysfunction. | N/A |
| Post: No change. | Post: No change. | ||||
| Post: 20% (8) abnormal cVEMP. | |||||
| Jin | Pre: 8% (1) reduced cVEMP, 42% (5) no cVEMP. | Not performed | Not performed | Not performed | N/A |
| Post: 100% (12) abnormal cVEMP. | |||||
| De Kegel | Pre: 26% (5) had abnormal cVEMP unilaterally or bilaterally. | Not performed | Not performed | Not performed | Significant drop in gross motor performance, recovering toward age 2. |
| Post: No change. | |||||
| Licameli | Pre: 12% (2) no cVEMP. | Not performed | Not performed | Not performed | Data not reliable collected, but no significant difference found. |
| Post: 84% (16) abnormal cVEMP. | |||||
| Devroede | Pre: 21% (5) abnormal cVEMP. | Pre: 71% (17) abnormal calorics. | Not performed | Not performed | Post-op dizziness in 33% (3) who had post-op vestiublar dysfunction, which subsequently recovered. |
| Post: 38% (9) abnormal cVEMP. | Post: 67% (16) abnormal calorics. | ||||
| Psillas | Pre: 30% (3) no cVEMP, 30% (3) reduced cVEMP. | Not performed | Not performed | Not performed | No dizziness, vertigo, instability, or nystagmus noted post-op. |
| Post: 100% (10) abnormal VEMP. | |||||
| Xu | Pre: 26% (6) abnormal cVEMP. | Not performed | Not performed | Not performed | N/A |
| Post: 65% (15) abnormal VEMP. | |||||
| Bogle | Pre: 0%abnormal cVEMP. | Not performed | Not performed | Not performed | N/A |
| Post: 20% (1) abnormal cVEMP. | |||||
| Gupta | Not performed | Pre: 22% (5) abnormal calorics. | Not performed | Not performed | N/A |
| Post: 35% (8) abnormal calorics. | |||||
| Hazzaa | Pre: 55% (22) abnormal or absent cVEMP. | Not performed | Not performed | Not performed | N/A |
| Post: 80% (32) abnormal or absent cVEMP at 6 months. |
Risk of bias assessment
| Study | Focused issue | Recruitment | Exposure accurately measured | Outcome accurately measured | Confounding factors | Follow up | Results | Precision of results | Believability of results | Applicability | Fit with evidence | Implications | Risk of bias |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ajalloueyan | Yes | Good | Yes | Yes | Steps taken to mitigate, limitations not formally addressed | Well documented | Well documented | Poor | Fair | Good | Unsure | Fair | B |
| Jin | Yes | Poor | Yes | Yes | Few steps taken to mitigate, limitations weakly addressed | Poorly described | Well documented | Fair | Fair | Good | Unsure | Unsure | C |
| De Kegel | Yes | Good | Yes | Yes | Steps taken to mitigate, limitations formally addressed | Well documented | Well documented | Fair | Good | Good | Unsure | Fair | A |
| Licameli | Yes | Good | Yes | Yes | Some steps taken to mitigate, limitations formally addressed | Well documented | Well documented | Fair | Good | Good | Good | Fair | A |
| Devroede | Yes | Fair | Yes | Yes | Steps taken to mitigate, limitations formally addressed | Well documented | Well documented | Fair | Fair | Good | Unsure | Fair | B |
| Psillas | Yes | Fair | Yes | Yes | Few steps taken to mitigate, limitations somewhat addressed | Well documented | Well documented | Fair | Fair | Good | Good | Unsure | B |
| Xu | Yes | Good | Yes | Yes | Some steps taken to mitigate, limitations somewhat addressed | Well documented | Well documented | Fair | Good | Good | Good | Fair | A |
| Thierry | Yes | Good | Yes | Yes | Steps taken to mitigate, limitations somewhat addressed | Well documented | Well documented | Fair | Good | Good | Good | Fair | A |
| Bogle | Yes | Poorly described | Yes | Poorly described | Not mitigated, limitations formally addressed | Poorly described | Poorly described, small sample size | Poor | Poorly described | Poor | Unsure | Poor | C |
| Gupta | Yes | Good | Yes | Yes | Some steps taken to mitigate, limitations not formally addressed | Well documented | Well documented | Fair | Fair | Good | Good | Fair | B |
| Hazzaa | Yes | Good | Yes | Yes | Some steps taken to mitigate, limitations not formally addressed | Well documented | Well described | Good | Good | Good | Good | Fair | A |
Fig. 2Meta-analysis Forest plots for VEMPs and caloric testing. 95% confidence intervals are included in parentheses. *Denotes a statistically significant result at the p < 0.05 level. ** Denotes a statistically significant result at the p < 0.001 level